Sensible Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Sensible Biotechnologies's estimated annual revenue is currently $1.6M per year.
- Sensible Biotechnologies's estimated revenue per employee is $77,500
Employee Data
- Sensible Biotechnologies has 21 Employees.
- Sensible Biotechnologies grew their employee count by 62% last year.
Sensible Biotechnologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | VP Clinical Research | Reveal Email/Phone |
4 | VP Manufacturing Strategy | Reveal Email/Phone |
5 | Head Operations | Reveal Email/Phone |
6 | VP Clinical Research | Reveal Email/Phone |
7 | Lab Director, Principal Computational Scientist | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | Senior Research Scientist | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
Sensible Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Sensible Biotechnologies?
At Sensible Biotechnologies, we are turning living cells into cost-efficient factories for manufacturing high-quality mRNA to unlock the full potential of mRNA therapeutics and vaccines.
keywords:N/AN/A
Total Funding
21
Number of Employees
$1.6M
Revenue (est)
62%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 21 | -9% | N/A |
#2 | $2.1M | 21 | -32% | N/A |
#3 | $3.3M | 21 | -12% | N/A |
#4 | $2.9M | 21 | -30% | N/A |
#5 | $2.1M | 21 | N/A | N/A |
